CPT-633

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCPT-633
Drug Alias NamePTP1B inhibitor (CEPTYR)PTP1B inhibitor (CEPTYR/Lilly)type 2 diabetes therapy (CEPTYR)type 2 diabetes therapy (CEPTYR/Lilly)obesity therapy (CEPTYR) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein tyrosine phosphatase inhibitorsInsulin sensitizers
TargetsProtein tyrosine phosphatase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCEPTYR Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCEPTYR IncEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A